G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease

Circulation

Volumn 103, Issue 20, 2001, Pages 2436-2440

  Russo, Carla ^a   Girelli, Domenico ^a   Olivieri, Oliviero ^a   Guarini, Patrizia ^a   Manzato, Franco ^a   Pizzolo, Francesca ^a   Zaia, Barbara ^a   Mazzucco, Alessandro ^a   Corrocher, Roberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Atherosclerosis; Coagulation; Coronary disease; Genetics; Risk factors

Indexed keywords

DNA; PROTHROMBIN;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035933001     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.20.2436     Document Type: Article

References (34)

1. The role of plaque rupture and thrombosis in coronary artery disease
2. Fibrinolytic and inflammatory markers for arterial occlusion: The evolving epidemiology of thrombosis and hemostasis
3. Hemostatic risk factors for cardiovascular disease
4. Physiology and biochemistry of prothrombin
5. A common genetic variation in the 3′ -untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
6. Prevalence of the prothrombin gene variant (nt 20210A) in venous thrombosis and arterial disease
7. Homozygotes for prothrombin gene 20210A allele in thrombophilic family without clinical manifestation of venous thromboembolism
8. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes
9. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives
10. Increased activation of the hemostatic system in men at high risk of fatal coronary heart disease
11. The G20210A prothrombin mutation and the physician's health study
12. The 20210 G→ A mutation in the 3′ untranslated region of the prothrombin gene and the risk for arterial thrombotic disease
13. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients
14. Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease
15. Interaction of coagulation defects and cardiovascular risk factors
16. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women
17. The factor II G20210A and factor V G1691A gene transitions and coronary heart disease
18. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men
19. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine and folate in subjects from Northern Italy with or without angiographically documented severe atherosclerotic disease: Evidence for an important genetic-environmental interaction
20. Lack of association of the prothrombin gene variant G20210A with myocardial infarction in Caucasian males
21. Coagulation factors II, V, VII, and X, prothrombin gene 20210 G→ A transition, and factor V Leiden in coronary artery disease: High factor V clotting activity is an independent risk factor for myocardial infarction
22. Prothrombotic genetic risk factors in young survivors of myocardial infarction
23. The prothrombin 20210 A allele and its association with myocardial infarction
24. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males
25. Risk of stroke in young women and two prothrombotic mutations: Factor V Leiden and prothrombin gene variant (G20210A)
26. Prevalence of the prothrombin gene variant 20210 G→ A among patients with myocardial infarction
27. The venous thrombosis risk factors 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease
28. Geographic distribution of the 20210 G to A prothrombin variant
29. Genetic dissection of complex traits
30. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and the risk of thrombosis
31. Oral contraceptives and cardiovascular disease
32. Pathogenesis of atherosclerosis
33. Mitogenic activity of blood components, I: Thrombin and prothrombin
34. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor